FABP7 and breast carcinoma: The findings of the prognostic analysis revealed that individuals with breast cancer who had FABP7 downregulation had a low chance of survival (Fig. 3A, P = 0.001) and upregulation of NDUFAB1 (Fig. 3B, P = 0.011).